Anaplasmosis is the second most common tick-borne disease in Canada, with rapidly rising incidence owing to the expanding ...

A 40-year-old man emigrated from India 2 years ago and has no prior medical conditions. He requested a clinic visit with his primary care provider (PCP) now that he is 40 years old. He has not been ...

Lisa D. Burry, Louise Rose, Ruxandra Pinto, David R. Williamson, Andrea Hill, Damon Scales, Susan E. Bronskill, Robert Fowler, Lisa Dolovich, Longdi Fu, Chaim M. Bell ...

Earn CPD Credits This article is eligible for .5 Mainpro+ credits. Did you read this article? Mainpro+ credits will be transferred automatically for members of the College of Family Physicians of ...

Background: Adverse events (AEs) are adverse outcomes caused by medical care. Several studies have indicated that a substantial number of patients experience AEs before or during hospitalization.

An α-2 adrenergic agonist approved only for veterinary use, medetomidine is similar to xylazine, but substantially more ...

Lecanemab is a monoclonal antibody therapy for early Alzheimer disease that is approved for use in Canada; however, Canada’s Drug Agency and Quebec’s Institut national d’excellence en santé et en ...

Background: Whether sedative prescriptions after hospital admissions are associated with poor patient outcomes is unknown. We sought to determine the incidence and risk of adverse events associated ...

Pulmonary embolism (PE) occurs when a venous thrombus becomes lodged in lung arteries, causing impairment in oxygenation, ...

Background: The Patented Medicine Prices Review Board (PMPRB), the agency that regulates the prices of patented medicines in Canada, published proposed amendments to the regulatory framework in ...

Background: Advocacy is a professional competency for Canadian physicians, yet adoption into medical education, academic medicine, and physician practice varies. We sought to explore perspectives on ...